Generic prescribing of antidepressants.

Area of Science:

• Pharmacoeconomics
• Drug utilization studies
• General practice

Background:

• Prescription practices for antidepressants have evolved significantly over time.
• Understanding trends in generic versus brand-name prescribing is crucial for healthcare economics.
• The National Health Service (NHS) provides a valuable dataset for analyzing drug prescribing patterns.

Purpose of the Study:

• To analyze the trend of generic name prescribing for antidepressants in the UK from 1980 to 1989.
• To compare the generic prescribing rates of different antidepressant drugs, particularly newer ones.
• To assess the impact of generic prescribing on actual dispensed medications.

Main Methods:

• Analysis of National Health Service (NHS) prescription data.
• Longitudinal study covering the period 1980 to 1989.
• Examination of prescription data for antidepressants, focusing on generic name usage.

Main Results:

• A consistent secular trend of increased generic name prescribing for antidepressants was observed.
• Newer antidepressants, such as fluvoxamine, fluoxetine, and amoxapine, exhibited higher generic prescribing rates upon introduction.
• The use of generic names on prescriptions did not consistently determine the dispensed medication, with pharmacists sometimes dispensing brand names.

Conclusions:

• Generic prescribing for antidepressants increased notably between 1980 and 1989.
• Newer antidepressant drugs may experience rapid adoption of generic prescribing.
• The influence of generic prescribing on dispensed medication is limited, as pharmacists may still dispense brand names.